SEC Form 4 · accession 0001209191-15-052482
Anacor Pharmaceuticals, Inc. · ANAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith R Leonard
Director
Period of report
Jun 9, 2015
Accepted (ET)
Jun 11, 2015 · 7:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2015 | A | 794 | $0.00 | A | 794 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $69.40 | Jun 9, 2015 | A | 4,096 | A | — | Jun 9, 2025 | Common Stock | 4,096 | 4,096 | D |
Explanation of responses
- F1Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. All of the shares subject to the award shall vest on the date preceding the date of the Issuer's 2016 Annual Meeting of Stockholders. Pursuant to an election previously made by the Reporting Person, settlement of vested restricted stock units will be deferred until the earlier of (i) the Reporting Person's separation from service with the Issuer or (ii) the occurrence of a change in control of the Issuer.
- F21/12th of the shares subject to the award shall vest and become exercisable in a series of twelve equal monthly installments measured from June 9, 2015.